ATNM
Actinium Pharmaceuticals, Inc.Company with tickers: ATNM
CIK
1388320
CUSIP
00507W206
Shares Outstanding
31,374,994
13F Activity (30d)
53 filings
51 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $5,903,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Research & Development | $4,201,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Operating Income | $-5,903,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Net Income | $-5,522,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| EPS (Basic) | $-0.18 | USD/shares | 2026-03-31 | 10-Q | 2026-05-08 |
| EPS (Diluted) | $-0.18 | USD/shares | 2026-03-31 | 10-Q | 2026-05-08 |